12-21-2021Cross-posted from NIAID NewsroomApproval Marks Pivotal Expansion of HIV Prevention Options in the United StatesYesterday the U.S. Food and Drug Administration a…
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in …
11-30-2021NIH-Funded Study Estimates Global Progress Toward UNAIDS GoalCross-posted from NIAID NewsroomAmong people with HIV worldwide who are receiving antiretroviral th…
11-12-2021Cross-posted from NIAID Now blogThe National Institutes of Health has awarded approximately $16 million to support implementation science research to advance th…
9-1-2021Cross-posted from NIAID newsroom No Safety Concerns Found in Imbokodo Sub-Saharan Africa StudyAn investigational HIV vaccine tested in the “Imbokodo” clinic…
8-19-2021Cross-posted from NIAID NewsroomThe National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 researc…
7-20-2021Adapted from National Institute of Allergy and Infectious Diseases emailPeople with HIV have significantly higher rates of cardiovascular disease than people wi…
7-8-2021Videos and posters are now available from the recent virtual National Ending the HIV Epidemic (EHE) Meeting of the NIH-funded Centers for AIDS Research (CFAR) a…
6-16-2021Cross-posted from NIH NewsroomA clinical trial is underway in five U.S. cities to determine whether delivering integrated health services through mobile clinics…
5-18-2021Cross-posted from NIAID Now blogWhile implementation of highly effective HIV treatment and prevention tools has reduced the HIV pandemic worldwide, development …
